glp 1 gentle patches GLP-1 Review: Innovation or Illusion? GLP-1 Gentle Patches Review |
Description
The pharma giant cites a report from the Brookings Institute that the FDA has never authorized or approved the manufacturing processes used by any of these foreign suppliers to make semaglutide, nor has the FDA ever reviewed or authorized the quality of the "semaglutide" they produce
The relevance of these mechanisms extends to neuropsychiatric domains
PMID 27569426
doi: 10.1097/MD.0000000000019762 14 VestergaardP
